Cardiac Rhythm Management
banner AtriCure 2019 journey surgeon

 

Activity Description

The webcast is comprised of proceedings from a satellite symposium at Heart Rhythm 2019.

This enduring educational activity reviews current challenges and existing barriers that exist with traditional AF treatment strategies, and examines the emerging role of the multidisciplinary hybrid ablation approach as well as adjunctive LAA closure, through clinical trial reviews, outcomes data assessments, and case study presentations.

Cardiac Rhythm Management

Access Webcast

Webcast

Click on the session title listed below to view each portion of the activity.

For those wishing to obtain your continuing medical education certification, access Earn CME Credit Tab at the conclusion of the webcast; select the appropriate answer to each posttest question, and successfully obtain the passing score as designated at the top of the test.

tmb AtriCure HRS2019 Hybrid Abl DeLurgio pres

Historical Review of Convergent Data and Clinical Study Update
David DeLurgio, MD, FACC, FHRS

play-webcast

tmb AtriCure HRS2019 Hybrid Abl Kress pres

Advantage of Multidisciplinary Hybrid Ablation Technique: A Surgeons Perspective
David Kress, MD, FACC, FACS

play-webcast

tmb AtriCure HRS2019 Hybrid Abl Makati pres

Convergent Ablation: Role of Posterior Left Atrial Wall as an Important Ablation Target
Kevin Makati, MD, FACC, FHRS

play-webcast

tmb AtriCure HRS2019 Hybrid Abl Yang pres

Convergent AF Ablation Combined with LAA Closure
Felix Yang, MD, FACC, FHRS

play-webcast

tmb AtriCure HRS2019 Hybrid Abl Panel

Panel Discussion
Moderator: David DeLurgio, MD, FACC, FHRS
Panel: David Kress, MD, FACC, FACS, Felix Yang, MD, FACC, FHRS, Kevin Makati, MD, FACC, FHRS

play-webcast

Cardiac Rhythm Management

Commercial Supporter

This activity is supported by an educational grant from AtriCure

Joint-Providers

MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Program Chair

tmb AtriCure HRS2019 Hybrid Abl DeLurgio port

David DeLurgio, MD, FACC, FHRS
Professor of Medicine
Division of Cardiology, Department of Medicine
Emory University School of Medicine
Atlanta, GA

Faculty

tmb AtriCure HRS2019 Hybrid Abl Kress port

David Kress, MD, FACC, FACS
Chief, Department of Cardiothoracic Surgery
Director, Surgical Arrhythmia Program
Aurora St. Luke’s Medical Center
Milwaukee, WI

tmb AtriCure HRS2019 Hybrid Abl Makati port

Kevin Makati, MD, FACC, FHRS
Assistant Professor
Cardiology Section, Department of Medicine
University of South Florida School of Medicine
Rhythm Section Chair, BayCare Health Systems
Tampa, FL

tmb AtriCure HRS2019 Hybrid Abl Yang port

Felix Yang, MD, FACC, FHRS
Associate Director of Cardiac Electrophysiology
Maimonides Medical Center,
Brooklyn, NY

 

CME Information

CME Released: 6/12/14/2019; Valid for credit through 6/12/2020

Target Audience

This activity is intended to meet the educational needs of electrophysiologists, cardiologists, fellows, and other physicians and associated healthcare professionals who are dedicated to the management of patients with Atrial Fibrillation.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review current challenges and existing barriers with traditional AF treatment strategies.
  • Examine the safety and efficacy of the Convergent procedural approach for treating Persistent or Longstanding Persistent AF.
  • Review the theoretical basis for targeting the posterior wall in NPAF patients.
  • Examine Convergent AF Ablation combined with LAA closure.

Accreditation Statement

Jointly Accredited Provider TM This activity has been planned and implemented by Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Ciné-Med designates this enduring activity for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1.5 contact hours for nurses.

Disclosure Policy

MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships are made known during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Faculty Disclosure Summary

Dr. David DeLurgio reports that he has received research support from AtriCure, and is a member of the speaker’s bureau for AtriCure.

Dr. David Kress reports that he is a consultant for Clinipace, AtriCure, and Advanced Cardiac Tissue Ablation Training Center of Excellence at Aurora St. Luke’s Medical Center. He also reports serving as Chair, Data Safety Monitoring Board, CONVERGE Multicenter IDE Trial (AtriCure, Inc. Sponsor)

Dr. Kevin Makati reports that he is a principal investigator and has received research support from Medtronic and Boston Scientific, and serves as a consultant, advisory board member, and faculty for Medtronic, Boston Scientific, Abbott, and AtriCure and has received research support from AtriCure.

Dr. Felix Yang reports that he is a member of the AtriCure speakers’ bureau and has received consulting fees and honoraria from Biosense Webster, Inc. and Abbott.

Non Endorsement Statement

MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on the title page; physicians and nurses should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™ or Contact Hours, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Review the educational presentations
  3. Select the appropriate answer to each posttest question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

Provider Contact Information

For technical support or CME/CE questions regarding this activity, please email us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Hardware/Software Requirements:

  • A computer with an Internet connection.
  • Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
  • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback.
  • Occasionally other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

MediaSphere protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MediaSphere and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. MediaSphere maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by MediaSphere Medical. All rights reserved. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from MediaSphere Medical

 

CME/CE Test

CME/CE Test
  1. An Integrated Approach to Managing the AF Patient: Exploring the Role of Convergent Hybrid Ablation
  2. Please enter your information, and complete the following CME post test and evaluation form. Upon successful completion, your submission will be reviewed and you will receive notification shortly regarding the status of your certificate. You must achieve a minimum score of 70% to earn credit for this activity.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Degree: *  
    Invalid Input
  7. Institution: *  
    Invalid Input
  8. Mailing Address:*  
    Invalid Input
  9. City: *  
    Invalid Input
  10. State: *  
    Invalid Input

  11. 1. It is concluded that only 15% of patients responded to a first procedure from the study evaluating Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint, as summarized by Dr. David DeLurgio within his presentation, Historical Review of Convergent Data and Clinical Study Update.
  12. Select one*  


    Invalid Input Please Select one

  13. 2. The Posterior Left Atrial Wall is an important source of substrate that contributes to the initiation and persistence of Atrial Fibrillation.
  14. Select one*  


    Invalid Input Please Select one

  15. 3. The major motivation for combined procedures with the multidisciplinary Hybrid Ablation Technique approach is to improve the efficacy of catheter ablation while decreasing complications of surgical ablation.
  16. Select one*  


    Invalid Input Please Select one

  17. 4. The Hybrid Ablation Technique offers the best of both worlds as it achieves catheter ablation efficacy closer to that of surgical maze, and surgical safety closer to that of catheter ablation.
  18. Select one*  


    Invalid Input Please Select one

  19. 5. The Posterior Left Atrial Wall is a viable target which can be ablated through a pericardioscopic approach and is potentially safer than an endocardial approach.
  20. Select one*  


    Invalid Input Please Select one

  21. 6. The Convergent AF ablation procedure combined with LAA closure with AtriClip has resulted in a high rate of Freedom from AF and Atrial Arrhythmias in a very difficult patient population.
  22. Select one*  


    Invalid Input Please Select one

  23. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  24. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  25. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  26. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  27. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  28. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  29. Review current challenges and existing barriers with traditional AF treatment strategies.
    Invalid Input Please Select one

  30. Examine the safety and efficacy of the Convergent procedural approach for treating Persistent or Longstanding Persistent AF.
    Invalid Input Please Select one

  31. Review the theoretical basis for targeting the posterior wall in NPAF patients.
    Invalid Input Please Select one

  32. Examine Convergent AF Ablation combined with LAA closure.
    Invalid Input

  33. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  34. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  35. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  36. Enhanced my current knowledge base:
    Invalid Input Please Select one

  37. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  38. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  39. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  40. Addressed a professional practice gap:
    Invalid Input Please Select one

  41. Was free of commercial bias/influence:
    Invalid Input Please Select one

  42. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  43. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  44. (*) Required Fields
  45. Invalid Input

Cardiac Rhythm Management